Tues­day Drugs de­vel­oped over­seas to be avail­able

China Daily (USA) - - NEWS CAPSULE -

Drugs de­vel­oped in other coun­tries are ex­pected to be avail­able for use on the Chi­nese main­land more quickly un­der a new guide­line re­leased by the cen­tral govern­ment.

China will now ac­cept data col­lected from clin­i­cal tri­als con­ducted out­side the main­land for ap­pli­ca­tions to reg­is­ter drugs and med­i­cal equip­ment, ac­cord­ing to the guide­line on re­form­ing ap­proval pro­ce­dures, which was re­leased by the State Coun­cil.

The data must be col­lected from clin­i­cal tri­als con­ducted at more than one cen­ter and must meet Chi­nese reg­u­la­tions for regis­tra­tion of drugs and med­i­cal equip­ment, the guide­line said.

“The pur­pose of the mea­sure is to re­duce the time needed for ap­proval of drugs from over­seas,” Wu Zhen, vice-min­is­ter of the China Food and Drug Ad­min­is­tra­tion, said on Mon­day.

China’s cur­rent drug eval­u­a­tion and ap­proval sys­tem needs im­prov­ing to ex­pe­dite the use of new drugs in China, Wu said.

Newspapers in English

Newspapers from China

© PressReader. All rights reserved.